[NEW GROWTH-STIMULANTS]. [electronic resource]
By: Contributor(s): Producer: 19961201Description: 960-3 p. digitalISSN:- 0002-3264
Publication Type: Journal Article
There are no comments on this title.
-
6881
Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
by Chang, C C -
6882
v-Rel activates the proto-oncogene c-Jun promoter: a correlation with its transforming activity.
by Fujii, M -
6883
Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas-related docking protein family, and its subsequent binding to the Src homology 2 domain of c-Crk.
by Kanda, H -
6884
Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.
by Horikawa, T -
6885
Expression and regulation of the thrombopoietin receptor variants MPLP and MPLK in PBMC.
by Rollinger-Holzinger, I -
6886
A functional genomics approach to Kaposi's sarcoma.
by Moses, Ashlee V -
6887
Cloning and activation of the Syrian hamster neu proto-oncogene.
by Nakamura, T -
6888
Prostaglandin E2-induced up-regulation of c-fos messenger ribonucleic acid is primarily mediated by 3',5'-cyclic adenosine monophosphate in MC3T3-E1 osteoblasts.
by Fitzgerald, J -
6889
SGK1, a potential regulator of c-fms related breast cancer aggressiveness.
by Tangir, Jacob -
6890
Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.
by Song, Li-Bing -
6891
Induction of intracellular signalling in human endothelial cells by the hyaluronan-binding protease involves two distinct pathways.
by Kress, Julia Anne -
6892
Diagnostic procedures in the follow-up of patients affected by MEN type 2.
by Seregni, Ettore -
6893
Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
by Swick, Brian L -
6894
Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus.
by Kyttaris, Vasileios C -
6895
Mechanism of transcriptional activation by the proto-oncogene Twist1.
by Laursen, Kristian Bruun -
6896
Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells.
by Sun, Jane -
6897
Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells.
by Kanayama, Seiji -
6898
A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
by Fiancette, Rémi -
6899
Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
by Themis, Michael -
6900
Gene regulation by BCL3 in a cervical cancer cell line.
by Maldonado, V
[NEW GROWTH-STIMULANTS].
APA
KUGATOVA SHEMIAKINA G. P., RUDENKO V. A., SMIRNOVA G. P., GRECHUSHNIKOV A. I., MISHUROVSKAIA L. M., AGAKISHIEV D. A., PENKOV L. A. & USHAKOVA V. F. (19961201). [NEW GROWTH-STIMULANTS]. : Doklady Akademii nauk SSSR.
Chicago
KUGATOVA SHEMIAKINA G P, RUDENKO V A, SMIRNOVA G P, GRECHUSHNIKOV A I, MISHUROVSKAIA L M, AGAKISHIEV D A, PENKOV L A and USHAKOVA V F. 19961201. [NEW GROWTH-STIMULANTS]. : Doklady Akademii nauk SSSR.
Harvard
KUGATOVA SHEMIAKINA G. P., RUDENKO V. A., SMIRNOVA G. P., GRECHUSHNIKOV A. I., MISHUROVSKAIA L. M., AGAKISHIEV D. A., PENKOV L. A. and USHAKOVA V. F. (19961201). [NEW GROWTH-STIMULANTS]. : Doklady Akademii nauk SSSR.
MLA
KUGATOVA SHEMIAKINA G P, RUDENKO V A, SMIRNOVA G P, GRECHUSHNIKOV A I, MISHUROVSKAIA L M, AGAKISHIEV D A, PENKOV L A and USHAKOVA V F. [NEW GROWTH-STIMULANTS]. : Doklady Akademii nauk SSSR. 19961201.